Eprosartan
TEVETEN
Pronunciation: ep-roe-SAR-tan
What it isAngiotensin II receptor blocker; hypertension.
Why this oneAlso blocks presynaptic AT1 receptors, giving some sympathoinhibition the other ARBs lack.
What limits itWeaker blood-pressure effect than the newer ARBs. Contraindicated in pregnancy.
Eprosartan prescription history
Animated chart of estimated U.S. prescriptions per year, RAAS inhibitors (1981–2026). Eprosartan enters in 1998 (estimated).
FDA-approved for
- hypertension (1997)
⚠ BOXED WARNING
- Fetal toxicity; discontinue as soon as pregnancy is detected
Principal riskWeaker blood-pressure effect than the newer ARBs
Classes and tags
Clinical profile
Legacy pregnancy categoryD
Defining liabilityFetal renal toxicity, hyperkalemia and renal dysfunction
Open Eprosartan in the interactive console ↗
Self-check
- What extra AT1 action may contribute to eprosartan’s effect?
Presynaptic sympathoinhibition. - Is eprosartan allowed in pregnancy?
No—contraindicated.